Commentary: Meta-analysis of individual participants' data in genetic epidemiology

American Journal of Epidemiology

Volumn 156, Issue 3, 2002, Pages 204-210

  Ioannidis, John P A ^a,b   Rosenberg, Philip S ^c   Goedert, James J ^c   O'Brien, Thomas R ^c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bias, epidemiology; Genetics; Meta analysis

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5;

EPIDEMIOLOGY; META-ANALYSIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMPARATIVE STUDY; ETHNIC DIFFERENCE; GENE DELETION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC MODEL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; META ANALYSIS; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RACE DIFFERENCE; SAMPLE SIZE;

BIAS (EPIDEMIOLOGY); CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE PROGRESSION; EPIDEMIOLOGIC MEASUREMENTS; GENETICS, MEDICAL; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HUMANS; META-ANALYSIS; RECEPTORS, CHEMOKINE;

EID: 0036682217     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf031     Document Type: Article

References (48)

1. Initial sequencing and analysis of the human genome
2. A map of human genome variation containing 1.42 million single nucleotide polymorphism
3. The future of genetic studies of complex human diseases
4. The new genomics: Global views of biology
5. Single nucleotide polymorphisms as tools in human genetics
6. Human genome epidemiologic reviews: The beginning of something HUGE
7. Replication validity of genetic association studies
8. Meta-analysis of observational studies in epidemiology: A proposal for reporting
9. Meta-analysis/shmeta-analysis
10. Qualitative assessment of studies included in a meta-analysis: DES and the risk of pregnancy loss
11. Of babies and bathwater
12. Traditional reviews, meta-analyses and pooled analyses in epidemiology
13. Meta-analysis of the literature or of individual patient data: Is there a difference?
14. Practical methodology of meta-analyses (overviews) using updated individual patient data
15. Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies
16. Homozygous defect in HIV-1 coreceptor accounts for resistance to some multiply-exposed individuals to HIV-1 infection
17. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
18. Genetic restriction of HIV-1 infection by a deletion allele of the CKR5 structural gene
19. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression: Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Study, ALIVE Study
20. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
21. Wrong kind of chemokine research
22. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rate of HIV-1 disease progression
23. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4
24. CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function
25. Effects of CCR5 Δ32, CCR2 641, and SDF-1 3′A polymorphisms of HIV-1 disease progression: An international meta-analysis of individual patient data
26. Genetic effects on HIV disease progression
27. Publication bias in clinical research
28. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials
29. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
30. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy
31. Regression models and life tables
32. Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data
33. Effect of radiotherapy and surgery in early breast cancer: An overview of the randomized trials
34. Bias in the one step method for pooling study results
35. Hazard function estimation using B-splines
36. Strategies for gene discovery
37. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations
38. Gm3;5,13,14 and type 2 diabetes mellitus: An association in American Indians with genetic admixture
39. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
40. Summing up evidence: One answer is not always enough
41. Genetic acceleration of AIDS progression by a promoter variant of CCR5
42. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection
43. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study, AIDS
44. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1
45. Cumulative metaanalysis of therapeutic trials for myocardial infarction
46. Evolution of treatment effects over time: Empirical evidence from recursive cumulative meta-analyses